Our results corroborate a review which summarized the results of 51 published studies on methylation analyses performed in cervical tissues and cells, which suggested that the combination of RARB, CADM1, and DAPK1 genes is the most promising methylation panel for obtaining an appropriate predictive tool of cervical cancer screening (28). The gene discussed is RARB; the disease is cervical carcinoma.